Sponsor Pipeline

Todd C. Lee MD MPH FIDSA Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
5
Recruiting
2
Phase 3
Active Trials by Phase
Phase 4
2
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06650488 Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus… Staphylococcus Aureus Endocarditis Recruiting
NCT06637332 Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia Staphylococcus Aureus Septicemia Recruiting
Phase 3
NCT07253688 Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus Staphylococcus Aureus Endocarditis Recruiting
NCT04851015 Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii… Pneumocystis Recruiting
Phase 2
NCT04886284 Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus… Staphylococcus Aureus Bacteremia Recruiting
Get alerts when Todd C. Lee MD MPH FIDSA's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free